Our Research – Leveraging Computational Technologies

Proteus uses computational tools and molecular modeling techniques to identify pre-clinical drug candidates that have therapeutic impact and selectivity.

more info

Recent Insights — Parkinson’s Disease and LRRK2

Proteus has developed a detailed molecular understanding of the most prevalent Parkinson's disease-related LRRK2 mutations, G2019S and I2020T.

more info

Scientific Inquiries — Collaboration and Partnering

Join our growing network of academic collaborators and commercial partners to advance the field of computational drug discovery and design.

more info